BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes
Proceedings of the National Academy of Sciences · 07.05.2024 · 121 (19)
DOI: 10.1073/pnas.2401386121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 02.05.2024. Verfasst von Long Bai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Reproductive Genetics (Ministry of Education) and Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zh…. Hauptthemen laut MEDLINE: Oocytes, BRCA1 Protein, Cell Cycle Proteins, Mice, Knockout. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province), Zhejiang Provincial Natural Science Foundation, MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
In the meiotic prophase, programmed DNA double-strand breaks are repaired by meiotic recombination. Recombination-defective meiocytes are eliminated to preserve genome integrity in gametes. BRCA1 is a critical protein in somatic homologous recombination, but studies have suggested that BRCA1 is dispensable for meiotic recombination. Here we show that BRCA1 is essential for meiotic recombination. Interestingly, BRCA1 also has a function in eliminating recombination-defective oocytes. Brca1 knockout (KO) rescues the survival of Dmc1 KO oocytes far more efficiently than removing CHK2, a vital component of the DNA damage checkpoint in oocytes. Mechanistically, BRCA1 activates chromosome asynapsis checkpoint by promoting ATR activity at unsynapsed chromosome axes in Dmc1 KO oocytes. Moreover, Brca1 KO also rescues the survival of asynaptic Spo11 KO oocytes. Collectively, our study not only unveils an unappreciated role of chromosome asynapsis in eliminating recombination-defective oocytes but also reveals the dual functions of BRCA1 in safeguarding oocyte genome integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Reproductive Genetics (Ministry of Education) and Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
- Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China.
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
- Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
- Zhejiang University Cancer Center, Hangzhou 310029, China.
ORCID-Profile: Peng Li, Jiyuan Chen, Yidan Liu, Yimin Zhu, Lin-Yu Lu
Förderung
- Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province)
- Zhejiang Provincial Natural Science Foundation
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Bai, L., Li, P., Xiang, Y., Jiao, X., Chen, J., Song, L., Liang, Z., Liu, Y., Zhu, Y., & Lu, L. Y. (2024). BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes. Proceedings of the National Academy of Sciences, 121(19). https://doi.org/10.1073/pnas.2401386121
Vancouver
Bai L, Li P, Xiang Y, Jiao X, Chen J, Song L, et al. BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes. Proceedings of the National Academy of Sciences. 2024;121(19). doi:10.1073/pnas.2401386121
BibTeX
@article{Bai2024,
author = {Bai, Long and Li, Peng and Xiang, Yu and Jiao, Xiaofei and Chen, Jiyuan and Song, Licun and Liang, Zhongyang and Liu, Yidan and Zhu, Yimin and Lu, Lin-Yu},
title = {BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {19},
doi = {10.1073/pnas.2401386121}
}
EUVIMED